Barrett et al., 2022 - Google Patents
Discovery solubility measurement and assessment of small molecules with drug development in mindBarrett et al., 2022
- Document ID
- 3549655963895270525
- Author
- Barrett J
- Yang W
- Skolnik S
- Belliveau L
- Patros K
- Publication year
- Publication venue
- Drug discovery today
External Links
Snippet
Highlights•Seamless solubility understanding requires discovery-development collaboration.•Gold standard methods in drug development map solubility of drug candidates.•Drug development solubility informs developability and drug product …
- 238000009509 drug development 0 title abstract description 34
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
- G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/15—Medicinal preparations; Physical properties thereof, e.g. dissolubility
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Barrett et al. | Discovery solubility measurement and assessment of small molecules with drug development in mind | |
O'Dwyer et al. | In vitro methods to assess drug precipitation in the fasted small intestine–a PEARRL review | |
Lipert et al. | Cocrystal transition points: role of cocrystal solubility, drug solubility, and solubilizing agents | |
Kuminek et al. | Posaconazole cocrystal with superior solubility and dissolution behavior | |
Aitipamula et al. | Polymorphs, salts, and cocrystals: what’s in a name? | |
Sun et al. | Virtual coformer screening by crystal structure predictions: Crucial role of crystallinity in pharmaceutical cocrystallization | |
Denninger et al. | A rational design of a biphasic dissolution setup—modelling of biorelevant kinetics for a ritonavir hot-melt extruded amorphous solid dispersion | |
Dai et al. | Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation | |
Chettri et al. | Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy | |
Gan et al. | Revisiting supersaturation of a biopharmaceutical classification system IIB drug: evaluation via a multi-cup dissolution approach and molecular dynamic simulation | |
Askin et al. | Olanzapine form IV: Discovery of a new polymorphic form enabled by computed crystal energy landscapes | |
Kuentz et al. | Rational selection of bio-enabling oral drug formulations–a PEARRL commentary | |
Stepanovs et al. | Cocrystals of pentoxifylline: in silico and experimental screening | |
Polster et al. | Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model | |
Guidetti et al. | Exploring the cocrystal landscape of posaconazole by combining high-throughput screening experimentation with computational chemistry | |
Štoček et al. | Importance of nuclear quantum effects for molecular cocrystals with short hydrogen bonds | |
Gan et al. | Supersaturation and precipitation applicated in drug delivery systems: Development strategies and evaluation approaches | |
Bahr et al. | Rapid screening approaches for solubility enhancement, precipitation inhibition and dissociation of a cocrystal drug substance using high throughput experimentation | |
Jeliński et al. | Experimental and theoretical study on theobromine solubility enhancement in binary aqueous solutions and ternary designed solvents | |
Dash et al. | Computational screening of multicomponent solid forms of 2-aryl-propionate class of NSAID, zaltoprofen, and their experimental validation | |
Sopyan et al. | Co-crystallization: a tool to enhance solubility and dissolution rate of simvastatin | |
Jeliński et al. | Quantification of Caffeine Interactions in Choline Chloride Natural Deep Eutectic Solvents: Solubility Measurements and COSMO-RS-DARE Interpretation | |
Niederquell et al. | Hydroxypropyl cellulose for drug precipitation inhibition: from the potential of molecular interactions to performance considering microrheology | |
Koyama et al. | Effect of seed particles on precipitation of weak base drugs in physiological intestinal conditions | |
Alinda et al. | Nucleation of supersaturated flufenamic acid cocrystal solutions in the presence of a polymer |